Last Updated: 02/03/2026
Formulation of a pan-species, multi-stage vaccine for the malaria eradication agenda
Objectives
The objectives are:
- to undertake the synthesis of the vaccine construct;
- to compare immunogenicity, formulation and efficacy of various vaccine constructs with a view to down-selecting the optimal combination to take to human clinical trial.
Principal Institution
Walter and Eliza Hall Institute of Medical Research (WEHI), Australia
Principal Investigators / Focal Persons
Rationale and Abstract
GNT 1093311 entitled ‘Formulation of a pan-species, multi-stage vaccine for the malaria eradication agenda’ seeks to undertake the preclinical development of a saccharide conjugate vaccine directed towards all major species and stages of malaria.
External reference
Themes
Date
Jan 2015 — Dec 2018
Total Project Funding
$567,934
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 1093311
AUD 755,447
Country / Project Site(s)
Related Resources
